Wells Fargo & Company Novavax Inc Transaction History

Wells Fargo & Company

$468 Billion
Q2 2025

A detailed history of Wells Fargo & Company transactions in Novavax Inc stock. As of the latest transaction made, Wells Fargo & Company holds 1,267,100 shares of NVAX stock, worth $10.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,267,100

Previous 1,785,200 29.02%

Holding current value

$10.7 Million

Previous $11.4 Million 30.25%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$5.43 - $7.74 $2.71 Million - $3.87 Million	499,438 Added 298.84%	666,564 $4.2 Million
Q1 2025 May 13, 2025	BUY	$6.41 - $10.82 $264,611 - $446,660	41,281 Added 32.8%	167,126 $1.07 Million
Q4 2024 Feb 12, 2025	BUY	$7.22 - $14.68 $216,462 - $440,121	29,981 Added 31.27%	125,845 $1.01 Million
Q3 2024 Nov 13, 2024	BUY	$10.71 - $17.11 $400,371 - $639,623	37,383 Added 63.92%	95,864 $1.21 Million
Q2 2024 Aug 13, 2024	BUY	$3.89 - $20.97 $59,649 - $321,553	15,334 Added 35.54%	58,481 $740,000
Q1 2024 May 10, 2024	BUY	$3.76 - $6.02 $39,758 - $63,655	10,574 Added 32.46%	43,147 $206,000
Q4 2023 Feb 09, 2024	SELL	$4.8 - $7.67 $873,897 - $1.4 Million	-182,062 Reduced 84.82%	32,573 $156,000
Q3 2023 Nov 13, 2023	SELL	$6.81 - $9.74 $388,919 - $556,251	-57,110 Reduced 21.02%	214,635 $1.55 Million
Q2 2023 Aug 15, 2023	BUY	$6.67 - $9.52 $521,447 - $744,254	78,178 Added 40.39%	271,745 $2.02 Million
Q1 2023 May 12, 2023	BUY	$5.76 - $12.48 $1.03 Million - $2.22 Million	178,161 Added 1156.44%	193,567 $1.34 Million
Q4 2022 Feb 13, 2023	SELL	$8.86 - $25.04 $12,324 - $34,830	-1,391 Reduced 8.28%	15,406 $158,000
Q3 2022 Nov 14, 2022	BUY	$18.2 - $76.12 $42,970 - $179,719	2,361 Added 16.35%	16,797 $306,000
Q2 2022 Aug 12, 2022	SELL	$36.28 - $75.29 $797,942 - $1.66 Million	-21,994 Reduced 60.37%	14,436 $742,000
Q1 2022 May 16, 2022	SELL	$69.73 - $142.9 $1.56 Million - $3.19 Million	-22,301 Reduced 37.97%	36,430 $2.68 Million
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $751,248 - $1.22 Million	5,583 Added 10.5%	58,731 $8.4 Million
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $4.36 Million - $6.64 Million	-24,522 Reduced 31.57%	53,148 $11 Million
Q2 2021 Aug 16, 2021	SELL	$121.0 - $257.67 $1.56 Million - $3.33 Million	-12,908 Reduced 14.25%	77,670 $16.5 Million
Q1 2021 May 13, 2021	SELL	$112.98 - $319.93 $1.31 Million - $3.72 Million	-11,621 Reduced 11.37%	90,578 $16.4 Million
Q4 2020 Feb 09, 2021	SELL	$78.74 - $139.5 $3.98 Million - $7.05 Million	-50,510 Reduced 33.08%	102,199 $11.4 Million
Q3 2020 Nov 05, 2020	SELL	$79.44 - $178.51 $174,370 - $391,829	-2,195 Reduced 1.42%	152,709 $16.5 Million
Q2 2020 Aug 13, 2020	BUY	$13.86 - $83.61 $1.81 Million - $10.9 Million	130,423 Added 532.75%	154,904 $12.9 Million
Q1 2020 May 14, 2020	BUY	$3.93 - $16.0 $96,210 - $391,696	24,481 New	24,481 $333,000

Others Institutions Holding NVAX

# of Institutions

317

Shares Held

94.6M

Call Options Held

6.38M

Put Options Held

10.6M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $663M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Novavax Inc Transaction History